1 Al-Riyami AZ, Louw VJ, Indrikovs AJ, Nedelcu E, Bakhtary S, Eichbaum QG, et al. Global survey of transfusion medicine curricula in medical schools: Challenges and opportunities ties. Transfusion. 2021;61(2):617-26. doi: 10.1111/trf.16147.

2 Almizraq RJ, Seghatchian J, Acker JP. Extracellular vesicles in transfusion-related immunomodulation and the role of blood component manufacturing. Transfus Apher Sci. 2016;55(3):281-91. doi: 10.1016/j.transci.2016.10.018.

3 Agência Nacional de Vigilância Sanitária (ANVISA). Boletim de Hemovigilância - Notificações de Reações Transfusionais 2022 [Internet]. Brasília: ANVISA; 2022 [cited 2025 Oct 27]. Available from: https://www.gov.br/anvisa/pt-br/assuntos/sangue-e-hemoderivados/hemovigilancia

4 Bagheri S, Hajiabadi F, Vahabzadeh R, Ahmadi MH. Investigating the impact of mitochondrial DNA: insights into blood transfusion reactions and mitigation strategies. Vox Sang. 2025;120(4):354-65. doi: 10.1111/vox.13794.

5 Bain CR, Myles PS, Martin C, Wallace S, Shulman MA, Corcoran T, et al. Postoperative systemic inflammation after major abdominal surgery: patient-centred outcomes. Anaesthesia. 2023;78(11):1365-75. doi: 10.1111/anae.16104.

6 Berg P, Heiden M, Müller S, Meyer B, Witzenhausen C, Ruppert-Seipp G, et al. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data. Vox Sang. 2024;119(9):953-62. doi: 10.1111/vox.13694.

7 Blumberg N, Farmer SL. Can Allogeneic Transfusions Harm Patients Undergoing Cancer Surgery? Anesth Analg. 2025;140(4):778-81. doi: 10.1213/ANE.0000000000007265.

8 Cata JP, Velasquez JF, Ramirez MF, Vauthey JN, Gottumukkala V, Conrad C, et al. Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol. 2017;15(1):152. doi: 10.1186/s12957-017-1220-6.

9 Céspedes IC, Figueiredo MS, Hossne NA Junior, Suriano ÍC, Rodrigues RC, Barros MMO, et al. Patient Blood Management Program Implementation: Comprehensive Recommendations and Practical Strategies. Braz J Cardiovasc Surg. 2024;39(5):e20240205. doi: 10.21470/1678-9741-2024-0205.

10 Chen YJ, Lin CL, Er TK. Trends and incidence of transfusion reactions: a single-center 5-year retrospective analysis. Clin Lab. 2025;71(4). doi: 10.7754/Clin.Lab.2024.241101.

11 Davies J, Tuckley V, McGrann A, Rowley M, Clarke H, Baker P, et al. SHOT UK Collaborative Reviewing and Reforming IT Processes in Transfusion (SCRIPT) survey: laboratory information management systems - are we ready for digital transformation? Transfus Med. 2023;33(6):433-9. doi: 10.1111/tme.13010.

12 Dorneles CC, Bodanese LC, Guaragna JC, Macagnan FE, Coelho JC, Borges AP, et al. O impacto da hemotransfusão na morbimortalidade pós-operatória de cirurgias cardíacas. Braz J Cardiovasc Surg. 2011;26(2):204-10. doi: 10.1590/S0102-76382011000200012.

13 U.S. Food and Drug Administration (FDA). Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2021 [Internet]. Silver Spring (MD): FDA; 2021 [cited 2025 Oct 27]. Available from: https://www.fda.gov/media/157074/download.

14 Farmer SL, Towler SC, Leahy MF, Hofmann A. Drivers for change: Western Australia Patient Blood Management Program (WA PBMP), World Health Assembly (WHA) and Advisory Committee on Blood Safety and Availability (ACBSA). Best Pract Res Clin Anaesthesiol. 2013;27(1):43-58. doi: 10.1016/j.bpa.2012.12.007.

15 Fishman JA. Infection in immunocompromised hosts and organ transplant recipients. N Engl J Med. 2011;364(26):2601-13. doi: 10.1056/NEJMra064928.

16 Jadwin DF, Fenderson PG, Friedman MT, Jenkins I, Shander A, Waters JH, et al. Determination of unnecessary blood transfusion by comprehensive 15-hospital record review. Jt Comm J Qual Patient Saf. 2023;49(1):42-52. doi: 10.1016/j.jcjq.2022.10.006.

17 Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347-58. doi: 10.1111/trf.14006.

18 Lin SY, Chang YL, Yeh HC, Lin CL, Kao CH. Blood transfusion and risk of venous thromboembolism: a population-based cohort study. Thromb Haemost. 2020;120(1):128-37. doi: 10.1055/s-0039-1697664.

19 Nilsson CU, Bentzer P, Andersson LE, Björkman SA, Hanssson FP, Kander T. Mortality and morbidity of low-grade red blood cell transfusions in septic patients: a propensity score-matched observational study of a liberal transfusion strategy. Ann Intensive Care. 2020;10(1):111. doi: 10.1186/s13613-020-00727-y.

20 Pavenski K, Howell A, Mazer CD, Hare GMT, Freedman J. ONTraC: a 20-year history of a successfully coordinated provincewide patient blood management program: lessons learned and goals achieved. Anesth Analg. 2022;135(3):448-58. doi: 10.1213/ANE.0000000000006065.

21 Public Health Agency of Canada. Transfusion Transmitted Injuries Surveillance System - 2022: Annual Report [Internet]. Ottawa: Government of Canada; 2023 [cited 2025 Oct 27]. Available from: https://www.canada.ca/en/public-health/services/publications/drugs-health-products/transfusion-transmitted-injuries-surveillance-system-2022.html

22 Said AS, Rogers SC, Doctor A. Physiologic impact of circulating RBC microparticles upon blood-vascular interactions. Front Physiol. 2018;8:1120. doi: 10.3389/fphys.2017.01120.

23 Samukange WT, Lu TA, Souverein PC, Gardarsdottir H, Mantel-Teeuwisse AK. Suspected adverse reactions reported for blood, blood components, and blood products in VigiBase. Transfusion. 2023;63(5):982-92. doi: 10.1111/trf.17336.

24 Sawyer RG, Claridge JA. Perioperative care of the immunocompromised patient. Surg Clin North Am. 2007;87(2):417-33.

25 SHOT. Serious Hazards of Transfusion annual report 2014 [Internet]. London: National Institute for Health and Care Excellence (NICE); 2015 Nov. (NICE Guideline No. 24). Available from: https://www.ncbi.nlm.nih.gov/books/NBK338800/

26 Uçkay I, Sax H, Pittet D. Surgical site infections in immunocompromised patients. Curr Opin Infect Dis. 2009;22(4):353-8.

27 Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev. 2007;21(6):327-48. doi: 10.1016/j.blre.2007.07.003.

28 Vargas LD, Garcia LO, Galvão AC, Onsten T, Sekine L. Blood transfusion-related immunomodulation. Clin Biomed Res. 2014;34(4):333-41.

29 Watt DG, Horgan PG, McMillan DC. Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review. Surgery. 2015;157(2):362-80. doi: 10.1016/j.surg.2014.09.009.

30 World Health Organization (WHO). The urgent need to implement patient blood management: policy brief [Internet]. Geneva: WHO; 2021 [cited 2025 Oct 27]. Available from: https://apps.who.int/iris/handle/10665/346655.

31 World Health Organization (WHO). Guidance on implementing patient blood management to improve global blood health status [Internet]. Geneva: WHO; 2024 [cited 2025 Oct 27]. Available from: https://iris.who.int/handle/10665/380784.

32 Zhang Y, Long H, Wang S, Xiao W, Xiong M, Liu J, et al. Genome-Wide DNA Methylation Pattern in Whole Blood Associated with Primary Intracerebral Hemorrhage. Front Immunol. 2021;12:702244. doi: 10.3389/fimmu.2021.702244.